bg
A

Annexon (ANNX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Annexon (ANNX)

Annexon, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s pipeline is based on its platform technology... Read more

  • USD4.75
  • USD5.06
  • USD4.69
  • USD8.40
  • -24.30%
  • --
  • 2.88M
  • 1.62M
  • 428M
  • 1.57
  • -3.70%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.